跳至主要内容
临床试验/NCT07711782
NCT07711782已完成不适用

Managing Polycystic Ovarian Syndrome- Associated Reproductive Dysfunction Through Kefir Supplementation

University of Lahore1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2026年1月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Lipid Profile

研究概览

简要总结

Polycystic ovary syndrome (PCOS) affect around 6-12% of women of age 18-25 years. Kefir contains bioactive compounds such as lactic acid bacteria, yeast, peptides, polysaccharides and organic acids and acts as a good probiotic source.

详细描述

The target population were females between the ages of 18 and 25 years who have the history of amenorrhea or delayed periods, unusual weight gain, cyst in their ovaries, hormonal imbalance or thyroid issue. Once consent is given, participants were then be randomly assigned to receive the prescribed intervention or act as a control.

(C0) Control group: Participants were only be subjected to use a regular calorie deficit diet plan (G1) Experimental group: Participants were advised to take water 250ml of water kefir per day in their mid-morning snack time for 2 months.

At baseline, nutritional assessment based on weight and height, BMI, waist circumference, blood pressure, fasting blood glucose, lipid panels (HDL, LDL, total cholesterol, triglycerides), FHS Levels, LH levels, TSH levels was done after 8 weeks of intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 25 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Females of age 18-25 will be selected.
  • Females suffering from amenorrhea or cycle longer then 35days were selected.
  • Females with PCOS were selected.
  • Females with BMI 18.5-29.9 were selected in this research.
  • Females with thyroid issues were selected.

排除标准

  • Pregnant and breast-feeding females were not included.
  • Those who smoke were not included.
  • Those who consume alcohol were not included.
  • Those suffering from endocrine diseases were not be included.
  • Those taking lipid- lowering drugs or blood pressure regulating medications were not be included.
  • Those taking antibiotics or medications related to PCOS treatment or vitamin-mineral or probiotics within 1 month prior to study inclusion.

结局指标

主要结局

Lipid Profile

时间窗: 8 weeks

Blood lipid profile were obtained using fasting blood samples to determine serum total cholesterol, high-density lipoprotein cholesterol (HD L-C), low density lipoprotein cholesterol (LDL-C) and triglycerides.

次要结局

  • FSH (follicle stimulating hormone)(8 weeks)
  • LH (luteinizing hormone)(8 weeks)

研究者

发起方
University of Lahore
申办方类型
Other
责任方
Principal Investigator
主要研究者

Maria Aslam

Clinical Head UIDNS

University of Lahore

研究点 (1)

Loading locations...

相似试验

Management of Polycystic Ovarian Syndrome-associated... | 临床试验